SCHEMBL10125879

SCHEMBL10125879

CCCc1cc2nc(-c3ccc(-c4ccc(-c5nc6ccccc6nc5-c5ccccc5)cc4)cc3)oc2cc1CCC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.46
KDM4E B2RXH2 4/20 0.46
NPC1 O15118 3/20 0.46
RAB9A P51151 3/20 0.46
CASP3 P42574 2/20 0.46
SENP7 Q9BQF6 2/20 0.46
SENP6 Q9GZR1 2/20 0.46
HPGD P15428 2/20 0.46
POLB P06746 2/20 0.46
SENP8 Q96LD8 1/20 0.46
ESR1 P03372 1/20 0.43
ESR2 Q92731 1/20 0.43
TDP1 Q9NUW8 2/20 0.42
ALDH1A1 P00352 3/20 0.42
MAPT P10636 1/20 0.42
PKM P14618 1/20 0.42
HSD17B10 Q99714 1/20 0.42
GPR119 Q8TDV5 9/20 0.41
CETP P11597 1/20 0.40
LMNA P02545 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10126049 0.97 ESR1 (0.44) SMN1; SMN2KDM4ENPC1RAB9ACASP3
SCHEMBL10125889 0.93 ESR1 (0.45) SMN1; SMN2KDM4ENPC1RAB9ACASP3
SCHEMBL10126051 0.90 ESR1 (0.46) SMN1; SMN2KDM4ENPC1RAB9ACASP3
SCHEMBL10125882 0.90 SMN1; SMN2 (0.48) SMN1; SMN2KDM4ENPC1RAB9ACASP3
SCHEMBL10126044 0.87 NPC1 (0.45) SMN1; SMN2KDM4ENPC1RAB9ACASP3
SCHEMBL10125891 0.84 KDM4E (0.45) SMN1; SMN2KDM4ENPC1RAB9ACASP3
SCHEMBL13621036 0.84 SMN1; SMN2 (0.47) SMN1; SMN2KDM4ENPC1RAB9ACASP3
SCHEMBL10125887 0.81 SMN1; SMN2 (0.44) SMN1; SMN2KDM4ENPC1RAB9ACASP3
SCHEMBL10125862 0.81 SMN1; SMN2 (0.55) SMN1; SMN2KDM4ENPC1RAB9ACASP3
SCHEMBL10125883 0.80 NPC1 (0.48) SMN1; SMN2KDM4ENPC1RAB9ACASP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119259-B2 Quinoxaline derivative, and light-emitting element and electronic device using the same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2012-02-21 US disclosed
US-20090140642-A1 Quinoxaline Derivative, and Light-Emitting Element and Electronic Device Using the Same SEMICONDUCTOR ENERGY LABORATORY CO., LTD. 2009-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090140642-A1 Quinoxaline Derivative, and Light-Emitting Element and Electronic Device Using the Same NDUFA11, NDUFA9, NDUFA12 SMN1; SMN2 3688/4885KDM4E 2216/4885NPC1 4763/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.